文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Analgesic Effects of Huwentoxin-IV on Animal Models of Inflammatory and Neuropathic Pain
侵权投诉

Analgesic Effects of Huwentoxin-IV on Animal Models of Inflammatory and Neuropathic Pain

Send Orders for Reprints to reprints@benthamscience.net

Protein & Peptide Letters, 2014, 21, 153-158

153

Analgesic Effects of Huwentoxin-IV on Animal Models of Inflammatory and Neuropathic Pain

Yu Liu, Zhe Wu, Dongfang Tang, Xiaohong Xun, Lichao Liu, Xianlei Li, Dongsong Nie, Yang Xiang, Jianming Yi and Jizu Yi*

College of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yueyang, 414006, China

Abstract: Huwentoxin-IV (HWTX-IV), a peptide with 35 amino acid residues, was discovered in the venom of spider Ornithoctonus huwena. The peptide had an inhibitory effect on a tetrodotoxin-sensitive (TTX-S) sodium channel with highly sensitive to Nav1.7, an attractive target for pain release therapy. In this study we further demonstrated the analgesic effects of HWTX-IV using mouse and rat as an inflammatory pain model and/or a neuropathic pain models. In the both cases, the analgesic effects of the peptide were dose-dependent, and statistically significant. In the inflammatory model, 100 g/kg of HWTX-IV produced an efficient reversal of hyperalgesia up to 63.6% after injection of formalin in rats with the efficiency equivalent to that of morphine at 50 g/kg, and 200 g/kg of HWTX-IV produced protective effect up to 55.6% after injection of acetic acid with the efficiency equivalent to that of morphine at 100 g/kg. In the spinal nerve model, the peptide produced the longer and higher reversal effect on allodynia than Mexiletine. These results demonstrated that HWTX-IV released efficiently the acute inflammatory pain and chronic neuropathic pain in these animals, suggesting that HWTX-IV was a potential and efficient candidate for further clinical drug development against inflammatory and neuropathic pain.

Keywords: Analgesic, huwentoxin-IV, inflammatory pain, neurotoxin, neuropathic pain. INTRODUCTION

Huwentoxin-IV (HWTX-IV), a 35-residue peptide (ECLEI FKACN PSNDQ CCKSS KLVCS RKTRW CKYQI), was discovered in tarantula Ornithoctonus huwena venom. The peptide amidated at its C-terminal end has a high proportion of basic residues, and six cysteine residues that form three intra-molecular disulfide bonds (Cys2-Cys17, Cys9-Cys24 and Cys16-Cys31). These disulfide bonds are required for its inhibitory activity of the peptide [1, 2]. HWTX-IV inhibited the neuronal tetrodotoxin-sensitive (TTX-S) sodium channels in rat dorsal root ganglion (DRG) cells, including neuronal voltage-gated sodium channels (VGSCs) specifically on subtypes rNav1.2, rNav1.3, and hNav1.7, compared with muscle subtypes rNav1.4 and hNav1.5. Of the five VGSCs examined, hNav1.7 was the greatest sensitive to HWTX-IV [1, 3, 4].

Among nine identified genes, namely Nav1.1-1.9, which encode sodium channels, each subtype gene can be function-ally classified as either tetrodotoxin-sensitive (TTX-S) or TTX-resistant (TTX-R) [5]. Both in vivo and in vitro studies indicated that VGSCs played a key role in pain reduction, which began with the aberrant firing of bursts in damaged neuronal tissue [6, 7]. Pharmacological and genetic data have provided evidence for specific involvement of Nav1.3, 1.7, 1.8, and 1.9 in the processing of nociceptive information [7].

*Address correspondence to this author at the College of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yuey-ang, 414006, China; Tel: +86-730-8640122; Fax: +86-730-8640122; E-mail: jizu_yi@yahoo.com

- 5/14 $58.00+.00

Over the last decade, there has been considerable debate re-garding which sodium channel would provide the best target for the development of novel analgesics [8]. Compelling genetic evidence linking Nav1.7 to pain in human beings was also provided by the observations of gain or loss of its functions after mutations in SCN9A, the gene encoding Nav1.7 [9-11]. These studies provide strong genetic evidence for the importance of Nav1.7 in pain [8].

Many peptide toxins from spiders have been identified to be highly potential and selective blockers of sodium chan-nels [9]. Some of these peptides are highly valuable as phar-macological tools and leading compound for developing human disease drugs. As sodium channel blockers were ef-fective analgesics when delivered at low concentrations [10], the present investigations were intended to further character-ize the antinociceptive effects of HWTX-IV on mouse and/or rat models of inflammatory and neuropathic pain. The results indicated that HWTX-IV produced dose-dependent attenua-tion of tactile allodynia on the animal models of inflam-matory and neuropathic pain, and suggested that HWTX-IV was indeed an effective candidate for further drug develop-ment against inflammatory and neuropathic pain. MATERIALS AND METHODS Peptide

HWTX-IV was synthesized on an automatic peptide synthesizer (PerSeptive Biosystems, Boston, MA) using an Fmoc/tert-butyl strategy and HOBt/TBTU/NMM coupling method [2, 11]. All amino acids were purchased from Che-© 2014 Bentham Science Publishers

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email